Potassium iodide and Enbrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium iodide (potassium iodide) and Enbrel (etanercept). Common drug interactions include blister among females and infection among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium iodide and Enbrel. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium iodide?

Potassium iodide has active ingredients of potassium iodide. It is often used in thyroid diseases. eHealthMe is studying from 1,919 Potassium iodide users. Check the latest studies of Potassium iodide.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.



On Jul, 30, 2026

11 people who take Potassium iodide and Enbrel together, and have interactions are studied.

Potassium iodide and Enbrel drug interactions.

What are the common drug interactions of Potassium Iodide and Enbrel, by gender? *:

female:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Diarrhoea
  3. Drug ineffective
  4. Drug intolerance (drug sensitivity)
  5. Feeling drunk
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Migraine (headache)
  9. Mouth haemorrhage (bleeding from mouth)
  10. Mouth ulceration (mouth ulcers)

male:

  1. Infection
  2. Cardiac arrest
  3. Pneumonia

What are the common drug interactions of Potassium Iodide and Enbrel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Dyspnoea (difficult or laboured respiration)
  3. General physical health deterioration (weak health status)
  4. Hypokalaemia (low potassium)
  5. Injection site erythema (redness at injection site)
  6. Injection site rash
  7. Mastoiditis (infection of mastoid bone)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)

10-19:

n/a

20-29:

  1. Arrhythmia (irregular heartbeat)
  2. Arthralgia (joint pain)
  3. Back pain
  4. Injection site pain
  5. Joint stiffness
  6. Myalgia (muscle pain)
  7. Nodule (a growth of abnormal tissue)
  8. Pain
  9. Pain in extremity
  10. Peripheral swelling

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Drug ineffective
  3. Drug intolerance (drug sensitivity)
  4. Dyspnoea (difficult or laboured respiration)
  5. Feeling drunk
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Migraine (headache)
  9. Mouth haemorrhage (bleeding from mouth)
  10. Mouth ulceration (mouth ulcers)

50-59:

n/a

60+:

  1. Infection
  2. Cardiac arrest
  3. Pneumonia

What are the existing conditions these people have? *

  1. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 2 people, 18.18%
  2. Tumor Pain: 1 person, 9.09%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 9.09%
  4. Nausea (feeling of having an urge to vomit): 1 person, 9.09%
  5. Myotonia (a state of hyperexcitability in muscle fibres in which a voluntary contraction): 1 person, 9.09%
  6. Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%
  7. Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 1 person, 9.09%
  8. Immunodeficiency: 1 person, 9.09%
  9. High Blood Pressure: 1 person, 9.09%
  10. Dyspnea (difficult or laboured breathing): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium iodide and Enbrel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium iodide and Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium iodide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium iodide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enbrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium iodide and etanercept (the active ingredients of Potassium iodide and Enbrel, respectively), and Potassium iodide and Enbrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: